MedTrace Logo

Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment

NCT05618912 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2024-12-11

Study results available
· View outcomes & findings →

Summary

Patients will be randomized either to receive standard daily dressing or hydrocolloid dressing using a randomization generator. After closing the wound with the sutures,the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days(Experimental) or the standard dressing (Control) that will be covered with petrolatum jelly and bandaging during this time period, which has to be re-applied daily. Patients and dermatologic surgeons will then complete surveys 7 days, 30 days, and 90 days after surgery to evaluate the cosmetic appearance of these scars.

Conditions

  • Scar
  • Skin Scarring
  • Skin Cancer
  • Wound Heal
  • Wound of Skin
  • Surgical Wound
  • Patient Satisfaction
  • Patient Preference
  • Surgical Incision

Interventions

DEVICE

Hydrocolloid dressing

A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery

OTHER

Petrolatum jelly dressing

The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-17
Primary Completion
2023-10-16
Completion
2023-10-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05618912 on ClinicalTrials.gov